Genetic signature

GENETIC2 trials

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain, National Institute of Cancerología

Conditions

Breast CancerCervix Cancer

Unknown Phase

Development of a Response Signature to Neoadjuvant Chemotherapy for Breast Cancer

Cliniques universitaires Saint-Luc- Université Catholique de LouvainBreast Cancer

Start: 2017-08-07End: 2019-12-31Target: 220Updated: 2019-07-15

Validation of the Genetic Signature 354849 as a Prognostic Method

National Institute of CancerologíaCervix Cancer

Start: 2019-09-30End: 2024-05-30Target: 189Updated: 2023-11-14